Mammoth Biosciences is a biotechnology company that develops CRISPR-based diagnostic tools. The company was founded in 2017 by Trevor Martin, Janice Chen, and Lucas Harrington. Mammoth's technology uses CRISPR to detect specific genetic sequences in a sample, allowing for rapid and accurate diagnosis of diseases. The company's technology has the potential to revolutionize the field of diagnostics, making it faster, cheaper, and more accessible. Mammoth has partnerships with a number of companies and research institutions, including GlaxoSmithKline and the University of California, Berkeley.